Glenmark, Janssen Settle Patent Dispute Over Generic Contraceptives
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Generics said it has reached a settlement with Janssen Pharmaceuticals in a patent dispute over branded generics of a pair of contraceptives.